Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 Aug 1;176(2):327–337. doi: 10.1084/jem.176.2.327

Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens

PMCID: PMC2119326  PMID: 1380059

Abstract

The lymphocyte activation gene 3 (LAG-3), expressed in human activated T and natural killer (NK) cells, is closely related to CD4 at the gene and protein levels. We report here the initial characterization of the LAG-3-encoded protein. We have generated two monoclonal antibodies after immunization of mice with a 30-amino acid peptide that corresponds to an exposed extra loop region present in the LAG-3 immunoglobulin-like first domain. The reactivity of these reagents is directed against LAG-3 since they recognize both membrane-expressed and soluble recombinant LAG-3 molecules produced in a baculovirus expression system. The two antibodies are likely to react with the same or closely related epitope (termed LAG-3.1) exposed on the LAG-3 first domain extra loop, as assessed in competition experiments on LAG-3- expressing activated lymphocytes. Cellular distribution analysis indicated that the LAG-3.1 epitope is expressed on activated T (both CD4+ and CD8+ subsets) and NK cells, and not on activated B cells or monocytes. In immunoprecipitation experiments performed on activated T and NK cell lysates, a 70-kD protein was detected after SDS-PAGE analysis. 45-kD protein species were also immunoprecipitated. Both the 70- and 45-kD proteins were shown to be N-glycosylated. In Western blot analysis, only the former molecule was recognized by the anti-LAG-3 antibodies, demonstrating that it is LAG-3 encoded. These anti-LAG-3 antibodies were used to investigate whether the LAG-3 protein interacts with the CD4 ligands. By using a high-level expression cellular system based on COS-7 cell transfection with recombinant CDM8 vectors and a quantitative cellular adhesion assay, we demonstrate that rosette formation between LAG-3-transfected COS-7 cells and human leukocyte antigen (HLA) class II-bearing B lymphocytes is specifically dependent on LAG-3/HLA class II interaction. In contrast to CD4, LAG-3 does not bind the human immunodeficiency virus gp120. This initial characterization will guide further studies on the functions of this molecule, which may play an important role in immune responses mediated by T and NK lymphocytes.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Accolla R. S. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subsets. J Exp Med. 1983 Mar 1;157(3):1053–1058. doi: 10.1084/jem.157.3.1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Accolla R. S., Sekaly R. P., McDonald A. P., Corte G., Gross N., Carrel S. Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets. Eur J Immunol. 1982 Feb;12(2):166–169. doi: 10.1002/eji.1830120212. [DOI] [PubMed] [Google Scholar]
  3. Baixeras E., Roman-Roman S., Jitsukawa S., Genevee C., Mechiche S., Viegas-Pequignot E., Hercend T., Triebel F. Cloning and expression of a lymphocyte activation gene (LAG-1). Mol Immunol. 1990 Nov;27(11):1091–1102. doi: 10.1016/0161-5890(90)90097-j. [DOI] [PubMed] [Google Scholar]
  4. Bosnes V., Qvigstad E., Lundin K. E., Thorsby E. Recognition of a particular HLA-DQ heterodimer by a human gamma/delta T cell clone. Eur J Immunol. 1990 Jul;20(7):1429–1433. doi: 10.1002/eji.1830200704. [DOI] [PubMed] [Google Scholar]
  5. Bénichou B., Strominger J. L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4285–4288. doi: 10.1073/pnas.88.10.4285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clayton L. K., Sieh M., Pious D. A., Reinherz E. L. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature. 1989 Jun 15;339(6225):548–551. doi: 10.1038/339548a0. [DOI] [PubMed] [Google Scholar]
  7. Crabtree G. R. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989 Jan 20;243(4889):355–361. doi: 10.1126/science.2783497. [DOI] [PubMed] [Google Scholar]
  8. Dimanche-Boitrel M. T., Guyot A., De Saint-Basile G., Fischer A., Griscelli C., Lisowska-Grospierre B. Heterogeneity in the molecular defect leading to the leukocyte adhesion deficiency. Eur J Immunol. 1988 Oct;18(10):1575–1579. doi: 10.1002/eji.1830181016. [DOI] [PubMed] [Google Scholar]
  9. Doyle C., Strominger J. L. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 1987 Nov 19;330(6145):256–259. doi: 10.1038/330256a0. [DOI] [PubMed] [Google Scholar]
  10. Fleury S., Lamarre D., Meloche S., Ryu S. E., Cantin C., Hendrickson W. A., Sekaly R. P. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell. 1991 Sep 6;66(5):1037–1049. doi: 10.1016/0092-8674(91)90447-7. [DOI] [PubMed] [Google Scholar]
  11. Gay D., Maddon P., Sekaly R., Talle M. A., Godfrey M., Long E., Goldstein G., Chess L., Axel R., Kappler J. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature. 1987 Aug 13;328(6131):626–629. doi: 10.1038/328626a0. [DOI] [PubMed] [Google Scholar]
  12. Golding H., Singer A. Specificity, phenotype, and precursor frequency of primary cytolytic T lymphocytes specific for class II major histocompatibility antigens. J Immunol. 1985 Sep;135(3):1610–1615. [PubMed] [Google Scholar]
  13. Hercend T., Reinherz E. L., Meuer S., Schlossman S. F., Ritz J. Phenotypic and functional heterogeneity of human cloned natural killer cell lines. Nature. 1983 Jan 13;301(5896):158–160. doi: 10.1038/301158a0. [DOI] [PubMed] [Google Scholar]
  14. Holter W., Goldman C. K., Casabo L., Nelson D. L., Greene W. C., Waldmann T. A. Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes. J Immunol. 1987 May 1;138(9):2917–2922. [PubMed] [Google Scholar]
  15. Jarvis D. L., Summers M. D. Glycosylation and secretion of human tissue plasminogen activator in recombinant baculovirus-infected insect cells. Mol Cell Biol. 1989 Jan;9(1):214–223. doi: 10.1128/mcb.9.1.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kozbor D., Trinchieri G., Monos D. S., Isobe M., Russo G., Haney J. A., Zmijewski C., Croce C. M. Human TCR-gamma+/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion. J Exp Med. 1989 May 1;169(5):1847–1851. doi: 10.1084/jem.169.5.1847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lamarre D., Ashkenazi A., Fleury S., Smith D. H., Sekaly R. P., Capon D. J. The MHC-binding and gp120-binding functions of CD4 are separable. Science. 1989 Aug 18;245(4919):743–746. doi: 10.1126/science.2549633. [DOI] [PubMed] [Google Scholar]
  18. Lamarre D., Capon D. J., Karp D. R., Gregory T., Long E. O., Sékaly R. P. Class II MHC molecules and the HIV gp 120 envelope protein interact with functionally distinct regions of the CD4 molecule. EMBO J. 1989 Nov;8(11):3271–3277. doi: 10.1002/j.1460-2075.1989.tb08487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lisowska-Grospierre B., Charron D. J., de Préval C., Durandy A., Griscelli C., Mach B. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J Clin Invest. 1985 Jul;76(1):381–385. doi: 10.1172/JCI111974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986 Nov 7;47(3):333–348. doi: 10.1016/0092-8674(86)90590-8. [DOI] [PubMed] [Google Scholar]
  21. Mazerolles F., Amblard F., Lumbroso C., Lecomte O., Van de Moortele P. F., Barbat C., Piatier-Tonneau D., Auffray C., Fischer A. Regulation of T helper-B lymphocyte adhesion through CD4-HLA class II interaction. Eur J Immunol. 1990 Mar;20(3):637–644. doi: 10.1002/eji.1830200326. [DOI] [PubMed] [Google Scholar]
  22. Mazerolles F., Durandy A., Piatier-Tonneau D., Charron D., Montagnier L., Auffray C., Fischer A. Immunosuppressive properties of synthetic peptides derived from CD4 and HLA-DR antigens. Cell. 1988 Nov 4;55(3):497–504. doi: 10.1016/0092-8674(88)90036-0. [DOI] [PubMed] [Google Scholar]
  23. Moingeon P., Ythier A., Goubin G., Faure F., Nowill A., Delmon L., Rainaud M., Forestier F., Daffos F., Bohuon C. A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature. 1986 Oct 16;323(6089):638–640. doi: 10.1038/323638a0. [DOI] [PubMed] [Google Scholar]
  24. Mourad W., Geha R. S., Chatila T. Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med. 1990 Nov 1;172(5):1513–1516. doi: 10.1084/jem.172.5.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Niman H. L., Houghten R. A., Walker L. E., Reisfeld R. A., Wilson I. A., Hogle J. M., Lerner R. A. Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A. 1983 Aug;80(16):4949–4953. doi: 10.1073/pnas.80.16.4949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nowill A., Moingeon P., Ythier A., Graziani M., Faure F., Delmon L., Rainaut M., Forrestier F., Bohuon C., Hercend T. Natural killer clones derived from fetal (25 wk) blood. Probing the human T cell receptor with WT31 monoclonal antibody. J Exp Med. 1986 Jun 1;163(6):1601–1606. doi: 10.1084/jem.163.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Odum N., Ledbetter J. A., Martin P., Geraghty D., Tsu T., Hansen J. A., Gladstone P. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G-specific monoclonal antibodies. Eur J Immunol. 1991 Sep;21(9):2121–2131. doi: 10.1002/eji.1830210921. [DOI] [PubMed] [Google Scholar]
  28. Pesando J. M., Graf L. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells. J Immunol. 1986 Jun 1;136(11):4311–4318. [PubMed] [Google Scholar]
  29. Piatier-Tonneau D., Gastinel L. N., Amblard F., Wojcik M., Vaigot P., Auffray C. Interaction of CD4 with HLA class II antigens and HIV gp120. Immunogenetics. 1991;34(2):121–128. doi: 10.1007/BF00211424. [DOI] [PubMed] [Google Scholar]
  30. Ruggiero G., Manzo C., Fontana S., Scala G., Pirozzi G., Ferrone S., Zappacosta S. Inhibition by anti-HLA class II monoclonal antibodies of monocyte-dependent T cell proliferation induced by monoclonal antibody OKT3. Eur J Immunol. 1987 Nov;17(11):1585–1592. doi: 10.1002/eji.1830171110. [DOI] [PubMed] [Google Scholar]
  31. Seed B. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. 1987 Oct 29-Nov 4Nature. 329(6142):840–842. doi: 10.1038/329840a0. [DOI] [PubMed] [Google Scholar]
  32. Shinohara N., Hozumi N., Watanabe M., Bluestone J. A., Johnson-Leva R., Sachs D. H. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones. J Immunol. 1988 Jan 1;140(1):30–36. [PubMed] [Google Scholar]
  33. Spits H., Ijssel H., Thompson A., de Vries J. E. Human T4+ and T8+ cytotoxic T lymphocyte clones directed at products of different class II major histocompatibility complex loci. J Immunol. 1983 Aug;131(2):678–683. [PubMed] [Google Scholar]
  34. Sutcliffe J. G., Shinnick T. M., Green N., Lerner R. A. Antibodies that react with predetermined sites on proteins. Science. 1983 Feb 11;219(4585):660–666. doi: 10.1126/science.6186024. [DOI] [PubMed] [Google Scholar]
  35. Triebel F., Graziani M., Faure F., Jitsukawa S., Hercend T. Cloned human CD3- lymphocytes with natural killer-like activity do not express nor rearrange T cell receptor gamma genes. Eur J Immunol. 1987 Aug;17(8):1209–1212. doi: 10.1002/eji.1830170819. [DOI] [PubMed] [Google Scholar]
  36. Triebel F., Jitsukawa S., Baixeras E., Roman-Roman S., Genevee C., Viegas-Pequignot E., Hercend T. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med. 1990 May 1;171(5):1393–1405. doi: 10.1084/jem.171.5.1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Triebel F., Missenard-Leblond V., Couty M. C., Charron D. J., Debre P. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies. J Immunol. 1984 Apr;132(4):1773–1778. [PubMed] [Google Scholar]
  38. Webb N. R., Madoulet C., Tosi P. F., Broussard D. R., Sneed L., Nicolau C., Summers M. D. Cell-surface expression and purification of human CD4 produced in baculovirus-infected insect cells. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7731–7735. doi: 10.1073/pnas.86.20.7731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. White J. M., Littman D. R. Viral receptors of the immunoglobulin superfamily. Cell. 1989 Mar 10;56(5):725–728. doi: 10.1016/0092-8674(89)90674-0. [DOI] [PubMed] [Google Scholar]
  40. Williams A. F., Barclay A. N. The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol. 1988;6:381–405. doi: 10.1146/annurev.iy.06.040188.002121. [DOI] [PubMed] [Google Scholar]
  41. Williams A. F., Davis S. J., He Q., Barclay A. N. Structural diversity in domains of the immunoglobulin superfamily. Cold Spring Harb Symp Quant Biol. 1989;54(Pt 2):637–647. doi: 10.1101/sqb.1989.054.01.075. [DOI] [PubMed] [Google Scholar]
  42. Ythier A., Moingeon P., Fabbi M., Delmon L., Nowill A., Troelen F., Bohuon C., Hercend T. Generation of monoclonal antibodies blocking cytotoxic reactions by human NK clones: further characterization of a 40/80-kDa target cell receptor. Cell Immunol. 1986 Apr 15;99(1):150–159. doi: 10.1016/0008-8749(86)90224-8. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES